Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward M Conway

Showing results (41-50 of 108) with videos related to

Pageof 11
Sort By:
The American Journal of Pathology|August 26, 2003
Survivin-dependent angiogenesis in ischemic brain: molecular mechanisms of hypoxia-induced up-regulationEdward M Conway, Femke Zwerts, Veerle Van Eygen, et al.
Oncogene|February 3, 2005
Survivin splice variants regulate the balance between proliferation and cell deathHugo Caldas, Yuying Jiang, Michael P Holloway, et al.
BMC Cancer|February 22, 2014
TGFβ-mediated suppression of CD248 in non-cancer cells via canonical Smad-dependent signaling pathways is uncoupled in cancer cellsSahana Suresh Babu, Yanet Valdez, Andrea Xu, et al.
Toxins|September 27, 2024
The Role of the N-Terminal Domain of Thrombomodulin and the Potential of Recombinant Human Thrombomodulin as a Therapeutic Intervention for Shiga Toxin-Induced Hemolytic-Uremic SyndromeSarah Kröller, Jana Schober, Nadine Krieg, et al.
Journal of Oncology|January 22, 2011
Survivin selectively modulates genes deregulated in human leukemia stem cellsSeiji Fukuda, Mariko Abe, Chie Onishi, et al.
ACS Nano|August 10, 2014
Modulation of complement activation and amplification on nanoparticle surfaces by glycopolymer conformation and chemistryKai Yu, Benjamin F L Lai, Jonathan H Foley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 4, 2012
Lack of the lectin-like domain of thrombomodulin worsens Shiga toxin-associated hemolytic uremic syndrome in miceCarlamaria Zoja, Monica Locatelli, Chiara Pagani, et al.
Blood|July 18, 2012
Thrombin generates previously unidentified C5 products that support the terminal complement activation pathwayMichael J Krisinger, Verena Goebeler, Zhen Lu, et al.
Arthritis and Rheumatism|August 20, 2010
CD248 and its cytoplasmic domain: a therapeutic target for arthritisMargarida Maia, Astrid de Vriese, Tom Janssens, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 29, 2005
Essential role for survivin in early brain developmentYuying Jiang, Alain de Bruin, Hugo Caldas, et al.
Pageof 11

Showing results (41-50 of 108) with videos related to

Sort By:
Pageof 11
The American Journal of Pathology|August 26, 2003
Survivin-dependent angiogenesis in ischemic brain: molecular mechanisms of hypoxia-induced up-regulationEdward M Conway, Femke Zwerts, Veerle Van Eygen, et al.
Oncogene|February 3, 2005
Survivin splice variants regulate the balance between proliferation and cell deathHugo Caldas, Yuying Jiang, Michael P Holloway, et al.
BMC Cancer|February 22, 2014
TGFβ-mediated suppression of CD248 in non-cancer cells via canonical Smad-dependent signaling pathways is uncoupled in cancer cellsSahana Suresh Babu, Yanet Valdez, Andrea Xu, et al.
Toxins|September 27, 2024
The Role of the N-Terminal Domain of Thrombomodulin and the Potential of Recombinant Human Thrombomodulin as a Therapeutic Intervention for Shiga Toxin-Induced Hemolytic-Uremic SyndromeSarah Kröller, Jana Schober, Nadine Krieg, et al.
Journal of Oncology|January 22, 2011
Survivin selectively modulates genes deregulated in human leukemia stem cellsSeiji Fukuda, Mariko Abe, Chie Onishi, et al.
ACS Nano|August 10, 2014
Modulation of complement activation and amplification on nanoparticle surfaces by glycopolymer conformation and chemistryKai Yu, Benjamin F L Lai, Jonathan H Foley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 4, 2012
Lack of the lectin-like domain of thrombomodulin worsens Shiga toxin-associated hemolytic uremic syndrome in miceCarlamaria Zoja, Monica Locatelli, Chiara Pagani, et al.
Blood|July 18, 2012
Thrombin generates previously unidentified C5 products that support the terminal complement activation pathwayMichael J Krisinger, Verena Goebeler, Zhen Lu, et al.
Arthritis and Rheumatism|August 20, 2010
CD248 and its cytoplasmic domain: a therapeutic target for arthritisMargarida Maia, Astrid de Vriese, Tom Janssens, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 29, 2005
Essential role for survivin in early brain developmentYuying Jiang, Alain de Bruin, Hugo Caldas, et al.
Pageof 11